Lack of a neuroprotective effect from N-acetylcysteine after cardiac arrest and resuscitation in a canine model

Resuscitation

Volumn 40, Issue 3, 1999, Pages 181-186

  Silbergleit, Robert ^b   Haywood, Yolanda ^a   Fiskum, Gary ^c   Rosenthal, Robert E ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Brain ischemia; Cardiac arrest; Drug therapy; Free radical; Neurologic dysfunction; Resuscitation

Indexed keywords

ACETYLCYSTEINE; SCAVENGER;

ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DOG; FEMALE; HEART ARREST; INTRAVENOUS DRUG ADMINISTRATION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION;

ACETYLCYSTEINE; ANIMALS; BRAIN ISCHEMIA; CARDIOPULMONARY RESUSCITATION; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOGS; FEMALE; FREE RADICAL SCAVENGERS; HEART ARREST; REFERENCE VALUES; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0033046386     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(99)00027-1     Document Type: Article

References (24)

1. Kristian T., Siesjo B. Calcium in ischemia cell death. Stroke. 29(3):1998;705-718.
2. Ginsberg M. The new language of cerebral ischemia. AJNR Am J Neuroradiol. 18(8):1997;1435-1445.
3. Maiese K. From the bench to the bedside: the molecular management of cerebral ischemia. Clin Neuropharmacol. 21(1):1998;1-7.
4. Pantoni L., Sarti C., Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterio Thromb Vasc Biol. 18:1998;503-513.
5. Thornberry N., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
6. Coyle J., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
7. Lee K., Yanamoto H., Fergus A. et al. Calcium-activated proteolysis as a therapeutic target in cerebrovascular disease. Ann NY Acad Sci. 825:1997;95-103.
8. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol. 71(4):1991;1185-1195.
9. RANTTAS Investigators. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). Stroke 1996;27(9):1453-58.
10. Knuckey N., Palm D., Primiano M., Epstein M., Johanson C. N-Acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats. Stroke. 26(2):1995;305-310.
11. Carroll J., Howard E., Hess D., Wakade C., Chen Q., Cheng C. Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res Mol Brain Res. 56(1):1998;186-191.
12. Lyrer P., Landolt H., Kabiersch A., Langemann H., Kaeser H. Levels of low molecular weight scavengers in the rat brain during focal ischemia. Brain Res. 567(2):1991;317-320.
13. Vanella A., Di Giacomo C., Sorrenti V. et al. Free radical scavenger depletion in post-ischemic reperfusion brain damage. Neurochem Res. 18(12):1993;1337-1340.
14. Egawa K., Yoshiwara M., Nose K. Effect of radical scavengers on TNF alpha-mediated activation of the uPA in cultured cells. Experientia. 50(10):1994;958-962.
15. Davreux C., Soric I., Nathens A. et al. N-Acetyl cysteine attenuates acute lung injury in the rat. Shock. 8(6):1997;432-438.
16. Fukuzawa K., Emre S., Senyuz O., Acarli K., Schwartz M.E., Miller C.M. N-Acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation. 59(1):1995;6-9.
17. Sala R., Moriggi E., Corvasce G., Morelli D. Protection by N-acetylcysteine against pulmonary endothelial cell damage induced by oxidant injury. Eur Respir J. 6(3):1993;440-446.
18. Rosenthal R., Williams R., Bogaert Y., Getson P., Fiskum G. Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke. 23(9):1992;1312-1317.
19. Yip L., Dart R.C., Hurlbut K.M. Intravenous administration of oral N-acetylcysteine. Crit Care Med. 26(1):1998;40-43.
20. Bircher N., Safar P. Cerebral preservation during cardiopulmonary resuscitation. Crit Care Med. 13:1985;185-190.
21. Rosenthal R.E., Hof P., Haywood Y., Silbergleit R., Fiskum G. Hyperbaric oxygen therapy prevents apoptotic and necrotic neuronal death following global cerebral ischemia (abstract). Acad Emerg Med. 4(5):1997;372.
22. Rosenthal R., Chanderbhan R., Marshall G., Fiskum G. Prevention of post-ischemic brain lipid conjugated diene production and neurological injury by hydroxyethyl starch-conjugated deferoxamine. Free Radic Biol Med (US). 12(1):1992;29-33.
23. Collis C.S., Davies M.J., Rice-Evans C. Comparison of N-methyl hexanoylhydroxamic acid, a novel antioxidant, with desferrioxamine and N-acetyl cysteine against reperfusion-induced dysfunctions in isolated rat heart. J Cardiovasc Pharmacol. 22(2):1993;336-342.
24. Broner C.W., Shenep J.L., Stidham G.L., Stokes D.C., Hildner W.K. Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice. Crit Care Med. 16(9):1988;848-851.